{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:01:15Z","timestamp":1794218475909,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","award":["EP\/T020997\/1"],"award-info":[{"award-number":["EP\/T020997\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","award":["EP\/V038036\/1"],"award-info":[{"award-number":["EP\/V038036\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007743","name":"European Society for Clinical Nutrition and Metabolism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022419","name":"National Institute for Health Research Southampton Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-20004"],"award-info":[{"award-number":["IS-BRC-20004"]}],"id":[{"id":"10.13039\/501100022419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206453\/Z\/17\/Z"],"award-info":[{"award-number":["206453\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.metabol.2023.155759","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T09:07:05Z","timestamp":1702458425000},"page":"155759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD"],"prefix":"10.1016","volume":"151","author":[{"given":"Josh","family":"Bilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina J.","family":"Oquendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Scorletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure B.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Baralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Calder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaswinder K.","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2023.155759_bb0005","first-page":"1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function","author":"Bilson","year":"2021","journal-title":"Proc Nutr Soc"},{"issue":"1 Suppl","key":"10.1016\/j.metabol.2023.155759_bb0010","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.metabol.2023.155759_bb0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.metabol.2023.155759_bb0020","first-page":"931","article-title":"Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Ng","year":"2022","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"17","key":"10.1016\/j.metabol.2023.155759_bb0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the Pan-PPAR agonist Lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.metabol.2023.155759_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamainternmed.2016.9607","article-title":"Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis","volume":"177","author":"Musso","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.metabol.2023.155759_bb0035","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15377","article-title":"Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals","volume":"42","author":"Saponaro","year":"2022","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.metabol.2023.155759_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123300","article-title":"Recent advances in adipose tissue dysfunction and its role in the pathogenesis of non-alcoholic fatty liver disease","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.metabol.2023.155759_bb0045","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.metabol.2023.155759_bb0050","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.metabol.2023.155759_bb0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","article-title":"Metabolic flexibility in health and disease","volume":"25","author":"Goodpaster","year":"2017","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.metabol.2023.155759_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2014an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.metabol.2023.155759_bb0065","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep.25805","article-title":"Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study","volume":"56","author":"Bell","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2023.155759_bb0070","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2023.155759_bb0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1210\/clinem\/dgac660","article-title":"Adipose tissue insulin resistance predicts the severity of liver fibrosis in patients with type 2 diabetes and NAFLD","volume":"108","author":"Kalavalapalli","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.metabol.2023.155759_bb0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1152\/physiol.00014.2014","article-title":"The gut-adipose-liver axis in the metabolic syndrome","volume":"29","author":"Konrad","year":"2014","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.metabol.2023.155759_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2014.02.020","article-title":"Gut-adipose tissue axis in hepatic fat accumulation in humans","volume":"61","author":"Munukka","year":"2014","journal-title":"J Hepatol"},{"issue":"572","key":"10.1016\/j.metabol.2023.155759_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.metabol.2023.155759_bb0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11695-007-9187-y","article-title":"Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease","volume":"17","author":"Baranova","year":"2007","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.metabol.2023.155759_bb0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease","volume":"149","author":"du Plessis","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.metabol.2023.155759_bb0105","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jhep.2011.12.015","article-title":"Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity","volume":"56","author":"Tordjman","year":"2012","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.metabol.2023.155759_bb0110","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.31822","article-title":"Increased adipose tissue fibrogenesis, not impaired expandability, is associated with nonalcoholic fatty liver disease","volume":"74","author":"Beals","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0115","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Synbiotics alter fecal microbiomes, but not liver fat or fibrosis, in a randomized trial of patients with nonalcoholic fatty liver disease","volume":"158","author":"Scorletti","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2023.155759_bb0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cct.2018.05.010","article-title":"Design and rationale of the INSYTE study: a randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease","volume":"71","author":"Scorletti","year":"2018","journal-title":"Contemp Clin Trials"},{"issue":"7","key":"10.1016\/j.metabol.2023.155759_bb0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.metabol.2023.155759_bb0130","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jc.2017-00047","article-title":"How to measure adipose tissue insulin sensitivity","volume":"102","author":"S\u00f8ndergaard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.aohep.2019.06.015","article-title":"Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis","volume":"18","author":"Gunes Yegin","year":"2019","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0140","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2023.155759_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis: original article","volume":"7","author":"Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0150","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.metabol.2023.155759_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.metabol.2023.155759_bb0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.metabol.2023.155759_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.metabol.2023.155759_bb0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"7","key":"10.1016\/j.metabol.2023.155759_bb0175","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1210\/jc.2017-00138","article-title":"The FAT score, a fibrosis score of adipose tissue: predicting weight-loss outcome after gastric bypass","volume":"102","author":"Bel Lassen","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"issue":"12","key":"10.1016\/j.metabol.2023.155759_bb0180","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1152\/physiolgenomics.00020.2016","article-title":"Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD","volume":"48","author":"Sheldon","year":"2016","journal-title":"Physiol Genomics"},{"issue":"8","key":"10.1016\/j.metabol.2023.155759_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104828","article-title":"A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity","volume":"25","author":"Meijnikman","year":"2022","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0190","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.2337\/db05-1421","article-title":"Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha","volume":"55","author":"Dahlman","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.metabol.2023.155759_bb0195","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1210\/jc.2013-3042","article-title":"Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size","volume":"99","author":"Yin","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 12","key":"10.1016\/j.metabol.2023.155759_bb0200","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1113\/jphysiol.2009.184754","article-title":"Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity","volume":"588","author":"Krauns\u00f8e","year":"2010","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0205","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1194\/jlr.R700005-JLR200","article-title":"Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation","volume":"48","author":"Sethi","year":"2007","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.metabol.2023.155759_bb0210","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.cdd.4402127","article-title":"Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin\/TCF4(TCF7L2)-dependent pathway","volume":"14","author":"Cawthorn","year":"2007","journal-title":"Cell Death Differ"},{"issue":"10","key":"10.1016\/j.metabol.2023.155759_bb0215","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0220","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jhep.2022.08.010","article-title":"Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease","volume":"77","author":"Pafili","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155759_bb0225","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/s41467-022-30629-5","article-title":"Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration","volume":"13","author":"Pedersen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2023.155759_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-physiol-060721-092930","article-title":"Adipose tissue fibrosis in obesity: etiology and challenges","volume":"84","author":"Marcelin","year":"2022","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"10.1016\/j.metabol.2023.155759_bb0235","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/oby.22463","article-title":"Adipose tissue CTGF expression is associated with adiposity and insulin resistance in humans","volume":"27","author":"Yoshino","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.metabol.2023.155759_bb0240","doi-asserted-by":"crossref","first-page":"E169","DOI":"10.1152\/ajpendo.00558.2020","article-title":"Fight against fibrosis in adipose tissue remodeling","volume":"321","author":"Li","year":"2021","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.metabol.2023.155759_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176030","article-title":"Adipose tissue fibrosis: mechanisms, models, and importance","volume":"21","author":"DeBari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2023.155759_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis \u2013 a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.metabol.2023.155759_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2023.155759_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals","author":"Mantovani","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.metabol.2023.155759_bb0265","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.metabol.2023.155759_bb0270","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.metabol.2023.155759_bb0275","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","article-title":"Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis","volume":"304","author":"Zeisberg","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"10.1016\/j.metabol.2023.155759_bb0280","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.metabol.2023.155759_bb0285","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1172\/JCI141828","article-title":"Decreased adipose tissue oxygenation associates with insulin resistance in individuals with obesity","volume":"130","author":"Cifarelli","year":"2020","journal-title":"J Clin Invest"},{"issue":"16","key":"10.1016\/j.metabol.2023.155759_bb0290","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1128\/MCB.00192-09","article-title":"Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue","volume":"29","author":"Halberg","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.metabol.2023.155759_bb0295","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41423-019-0296-z","article-title":"NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling","volume":"18","author":"Unamuno","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"19","key":"10.1016\/j.metabol.2023.155759_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910541","article-title":"A distinctive NAFLD signature in adipose tissue from women with severe obesity","volume":"22","author":"Osorio-Conles","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.metabol.2023.155759_bb0305","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis","volume":"75","author":"Selvaraj","year":"2021","journal-title":"J Hepatol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523003633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523003633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T02:32:41Z","timestamp":1731724361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049523003633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":61,"alternative-id":["S0026049523003633"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155759","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155759"}}